Literature DB >> 10815146

Treatment of ocular myasthenia: steroids only when compelled.

H J Kaminski1, R B Daroff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10815146     DOI： 10.1001/archneur.57.5.752

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  10 in total

1.  Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.

Authors:  Michael Benatar; Michael P Mcdermott; Donald B Sanders; Gil I Wolfe; Richard J Barohn; Richard J Nowak; Michael Hehir; Vern Juel; Hans Katzberg; Rabi Tawil
Journal:  Muscle Nerve       Date:  2016-01-27       Impact factor: 3.217

2.  Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.

Authors:  M J Kupersmith; G Ying
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  Safety of prednisone for ocular myasthenia gravis.

Authors:  Beau B Bruce; Mark J Kupersmith
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

4.  Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.

Authors:  Mark J Kupersmith
Journal:  J Neurol       Date:  2009-04-18       Impact factor: 4.849

5.  Generalization after ocular onset in myasthenia gravis: a case series in Germany.

Authors:  Feng Li; Benjamin Hotter; Marc Swierzy; Mahmoud Ismail; Andreas Meisel; Jens-C Rückert
Journal:  J Neurol       Date:  2018-09-17       Impact factor: 4.849

6.  Ocular myasthenia gravis: controversies and updates.

Authors:  Sui H Wong; Saif Huda; Angela Vincent; Gordon T Plant
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

7.  Surgical treatment for medically refractory myasthenic blepharoptosis.

Authors:  Yusuke Shimizu; Shigeaki Suzuki; Tomohisa Nagasao; Hisao Ogata; Masaki Yazawa; Norihiro Suzuki; Kazuo Kishi
Journal:  Clin Ophthalmol       Date:  2014-09-19

8.  Characterization of patients with ocular myasthenia gravis - A case series.

Authors:  Arnon Karni; Ali Asmail; Vivian E Drory; Hadar Kolb; Anat Kesler
Journal:  eNeurologicalSci       Date:  2016-04-25

9.  An adult patient with ocular myasthenia and unusually long spontaneous remission.

Authors:  Jasem Al-Hashel; Hanaa M Rashad; Rossen T Rousseff
Journal:  Case Rep Neurol Med       Date:  2014-04-13

10.  Quality of life in purely ocular myasthenia in Japan.

Authors:  Shigeaki Suzuki; Hiroyuki Murai; Tomihiro Imai; Yuriko Nagane; Masayuki Masuda; Emiko Tsuda; Shingo Konno; Satoru Oji; Shunya Nakane; Masakatsu Motomura; Norihiro Suzuki; Kimiaki Utsugisawa
Journal:  BMC Neurol       Date:  2014-07-05       Impact factor: 2.474
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.